IP Protection for Startups: The Role of Legislation in Stopping Patent Trolls and Encouraging Innovation
Kristin Garr In the past five years, the rate of startups entering the market has drastically increased, and it continues to see an upward trend, giving rise to the phenomenon known as the “startup boom.” While the United States Patent and Trademark Office (“USPTO”) has implemented major changes to the patent system in the past decade, the agency has not been able to address the problem that is crippling the success of emerging companies: patent trolls. Various states’ legislatures have recognized this issue and enacted statutes prohibiting bad faith patent assertions as a result. This article explains the startup industry’s...
Allergan’s Battle to Stay in Court: Does Inter Partes Review Violate the Constitution by Circumventing Courtroom Adjudication?
Ashley E. Petrarca Since its institution in 2011, inter partes review has caused considerable disruption in the intellectual property world, with some industry players questioning the process’ constitutionality. One of these players is Dublin-based pharmaceutical company Allergan, Inc., which asserts that it is unfair to force patent owners to defend their USPTO-granted patent rights before the Patent Trial and Appeal Board (“PTAB”), a non-Article III sanctioned forum. Central to this debate is the question of whether patents confer private or public rights. This article discusses both sides of the dialogue over inter partes review constitutionality, and postulates that the process...